Por: The New York Times Health August 08, 2023
A new obesity drug, Wegovy, slashed the risk of serious heart problems by 20 percent in a large trial, the drug’s maker said on Tuesday, a finding that could challenge the perception of weight loss drugs as nothing more than cosmetic medicines and put pressure on insurers to cover them.The trial was the first to demonstrate that the new class of obesity drugs could bring lasting benefits to heart health for people who were overweight but did... + full article
New York Post USA Life July 06, 2023
When Eli Diaz lost 22 pounds in three months from taking diabetes drug Wegovy for weight loss, she thought she had found a miracle fix. She felt more confident than ever in form-fitting leggings and sleeveless tops. Diaz, 36, a mom of three who runs a Naples, Florida,... + más
What Are the Duties of A Trustee? | Forbes
NBA playoffs 2023: Our insiders dissect the Eastern and Western conference finals | ABC7
Time USA Health June 26, 2023
Weight loss drugs are having a moment, owing to the fact that pharmaceutical companies have figured out how to help people lose up to double-digit percentages of their body weight and start dropping a more substantial number of pounds. Although Ozempic, Wegovy, and Rybelsus, all... + más
Spicy food eaters more likely to consider themselves attractive: poll | New York Post
Cancer drug shortage ‘is absolute lunacy,’ doctors say: ‘Lives will be shortened’ | New York Post
Orlando Sentinel USA Business April 27, 2023
As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment. Tirzepatide, an Eli Lilly and Co. drug approved to treat type 2... + más
NFL Playoff Scenarios | ABC News
Use drugs and surgery early for obesity in kids, new guidance says | Orlando Sentinel
ABC News USA Health April 27, 2023
As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on to pare pounds — an even more powerful obesity medicine is poised to upend treatment.Tirzepatide, an Eli Lilly and Co. drug approved to treat type 2 diabetes under... + más
Obesity in 2035 could be just as costly as COVID in 2020 | WPTV
Half Of Global Population Will Be Overweight In 12 Years: Study | RTTNews
ABC7 USA World April 27, 2023
As a growing number of overweight Americans clamor for Ozempic and Wegovy -- drugs touted by celebrities and on TikTok to pare pounds -- an even more powerful obesity medicine is poised to upend treatment.Tirzepatide, an Eli Lilly and Co. drug approved to treat type 2 diabetes... + más
Popular diabetes drug Mounjaro could be FDA-approved for weight loss this year, company says | ABC News
Popularity of Ozempic, Mounjaro, similar drugs may be driving shortages for people with diabetes, obesity | ABC News
New York Post USA Life April 12, 2023
Weight loss — often regarded as the first step to good health — could actually be a death sentence later in life. A new study found that healthy older adults who lose considerable weight are more at risk of premature death from cancer, cardiovascular disease “and other... + más
World’s fattest countries revealed: Where does America fall on the list? | New York Post
‘Worrying’ global obesity projections for 2035 revealed in new report | New York Post
New York Post USA Life January 06, 2023
Secrets, secrets, they’re no fun — especially when you don’t share your diet with someone. A new study found that 57% of dieters have not told anyone about their weight loss attempts, and 35% said they keep their endeavors hushed so no one would know if they failed.... + más
A new era of weight-loss gadgets is here — but for dieters, there's no easy answer | CBS News
Opinion | The New York Times
About iurex | Privacy Policy | Disclaimer |